Pedro Costa A, da Silva Brito I, Mestre T, Matos Pires A, Jose Lopes M
Healthcare (Basel). 2025; 13(5).
PMID: 40077101
PMC: 11898782.
DOI: 10.3390/healthcare13050539.
Turner E, Mueller C
Community Ment Health J. 2025; .
PMID: 39885098
DOI: 10.1007/s10597-024-01445-6.
Slayter J, Casey L, McCullum S, Drost D, Banks A, OConnell C
J Rehabil Med. 2025; 57():jrm41254.
PMID: 39810476
PMC: 11748171.
DOI: 10.2340/jrm.v57.41254.
Magnavita N, Meraglia I, Ricco M
AIMS Public Health. 2025; 11(4):1223-1246.
PMID: 39802561
PMC: 11717537.
DOI: 10.3934/publichealth.2024063.
Iorfino F, Oliveira R, Cripps S, Marchant R, Varidel M, Capon W
Eur Psychiatry. 2024; 67(1):e87.
PMID: 39697104
PMC: 11733617.
DOI: 10.1192/j.eurpsy.2024.1787.
The importance of including a mental health dimension in a multimorbidity indicator: an analysis of Belgian health survey data.
Laloux P, Gisle L, Dhoore W, Charafeddine R, Van der Heyden J
BMC Public Health. 2024; 24(1):3465.
PMID: 39695533
PMC: 11657147.
DOI: 10.1186/s12889-024-21028-0.
Measuring the Well-Being of the Whole Person in Clinical Care, Health Research, and Population Health Evaluation: Findings and Recommendations From the XVIII Veterans Health Administration State of the Art Meeting.
Vogt D, Kligler B, Darchuk K, Elbogen E, List J, McMullen T
Med Care. 2024; 62(12 Suppl 1):S4-S12.
PMID: 39514485
PMC: 11548809.
DOI: 10.1097/MLR.0000000000002084.
Affective disorders: eliminate WArning signs And REstore functioning: AWARE. Results from a randomized controlled multimodular intervention study targeting functioning in patients with affective disorders.
Schwarz R, Miskowiak K, Christensen M, Kessing L, Vinberg M
Psychol Med. 2024; :1-10.
PMID: 39479758
PMC: 11578905.
DOI: 10.1017/S0033291724002526.
From antidepressants and psychotherapy to oxytocin, vagus nerve stimulation, ketamine and psychedelics: how established and novel treatments can improve social functioning in major depression.
Kupferberg A, Hasler G
Front Psychiatry. 2024; 15:1372650.
PMID: 39469469
PMC: 11513289.
DOI: 10.3389/fpsyt.2024.1372650.
Cognitive Orientation to daily Occupational Performance (CO-OP) for mood, anxiety, and adjustment disorders: a pilot study.
Wong S, Chan M, Chong E, Dancza K
Front Psychiatry. 2024; 15:1428811.
PMID: 39391086
PMC: 11464456.
DOI: 10.3389/fpsyt.2024.1428811.
The Work and Social Adjustment Scale (WSAS): An investigation of reliability, validity, and associations with clinical characteristics in psychiatric outpatients.
Lundqvist J, Lindberg M, Brattmyr M, Havnen A, Hjemdal O, Solem S
PLoS One. 2024; 19(10):e0311420.
PMID: 39388411
PMC: 11466382.
DOI: 10.1371/journal.pone.0311420.
A semi-structured interview for the dimensional assessment of internalizing and externalizing symptoms in children and adolescents: Interview Version of the Symptoms and Functioning Severity Scale (SFSS-I).
Rausch J, Bickman L, Geldermann N, Oswald F, Gehlen D, Gortz-Dorten A
Child Adolesc Psychiatry Ment Health. 2024; 18(1):106.
PMID: 39182121
PMC: 11344912.
DOI: 10.1186/s13034-024-00788-y.
Efficacy and safety of a mineral and vitamin treatment on symptoms of antenatal depression: 12-week fully blinded randomised placebo-controlled trial (NUTRIMUM).
Bradley H, Moltchanova E, Mulder R, Dixon L, Henderson J, Rucklidge J
BJPsych Open. 2024; 10(4):e119.
PMID: 38828982
PMC: 11363078.
DOI: 10.1192/bjo.2024.706.
Prospective trajectories of depression predict mortality in cancer patients.
Sanghvi D, Chen M, Bonanno G
J Behav Med. 2024; 47(4):682-691.
PMID: 38615300
DOI: 10.1007/s10865-024-00485-3.
A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une évaluation randomisée de MoodFX, un outil de santé en ligne centré sur le patient pour soutenir la mesure du résultat dans la....
Li V, Sahota J, Dev D, Gill D, Evans V, Axler A
Can J Psychiatry. 2024; 69(7):493-502.
PMID: 38600892
PMC: 11168344.
DOI: 10.1177/07067437241245331.
Exploring the Effects of Major Depressive Disorder on Daily Occupations and the Impact of Psychotherapy: A Literature Review.
Iliou K, Balaris D, Dokali A, Fotopoulos V, Kouletsos A, Katsiana A
Cureus. 2024; 16(3):e55831.
PMID: 38590479
PMC: 11000031.
DOI: 10.7759/cureus.55831.
The relationship between expressive suppression, therapeutic bond, and treatment outcomes of a positive affect intervention for adults with anxiety and/or depression.
Hoffman S, Stein M, Taylor C
Cogn Behav Ther. 2024; 53(4):394-408.
PMID: 38483053
PMC: 11076159.
DOI: 10.1080/16506073.2024.2321891.
Prevalence of mental disorders among middle-aged population of primary healthcare centers in Northeastern Iran.
Talebi M, Taghipour A, Raouf-Rahmati A, Farokhani E, Ghaffariyan-Jam S, Samarghandi A
BMC Public Health. 2024; 24(1):80.
PMID: 38172756
PMC: 10763134.
DOI: 10.1186/s12889-023-17598-0.
Revisiting the theoretical and methodological foundations of depression measurement.
Fried E, Flake J, Robinaugh D
Nat Rev Psychol. 2023; 1(6):358-368.
PMID: 38107751
PMC: 10723193.
DOI: 10.1038/s44159-022-00050-2.
Symptoms and prevalence of common mental disorders in a heterogenous outpatient sample: an investigation of clinical characteristics and latent subgroups.
Brattmyr M, Lindberg M, Lundqvist J, Solem S, Hjemdal O, Anyan F
BMC Psychiatry. 2023; 23(1):804.
PMID: 37924053
PMC: 10623879.
DOI: 10.1186/s12888-023-05314-6.